Development and validation of an anastomotic risk score for use in a randomized clinical trial on defunctioning stoma use in low anterior resection for rectal cancer
Colorectal Disease · 2025
DOI: 10.1111/codi.70089 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Colorectal Disease, 2025. Verfasst von Martin Rutegård und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostics and Intervention, Surgery, Umeå University, Umeå, Sweden. Hauptthemen laut MEDLINE: Rectal Neoplasms, Anastomotic Leak, Proctectomy, Surgical Stomas. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetenskapsrådet, Cancerföreningen i Stockholm, Astma- och Allergiförbundet.
Abstract (Originalsprache)
Aim
The selective use of defunctioning stomas in anterior resection for rectal cancer hinges on accurately predicting anastomotic leakage. The aim of this study was to develop a prediction model for use in a prospective randomized clinical trial.
Method
Colorectal Cancer Database (CRCBaSe) Sweden was used to identify patients who underwent low anterior resection for rectal cancer 2007–2021. Eligibility criteria mirrored the forthcoming SELective defunctioning Stoma Approach in low anterior resection for rectal cancer (SELSA) trial, including patients 10% risk is considered appropriate for trial use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Diagnostics and Intervention, Surgery, Umeå University, Umeå, Sweden.
- Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
- Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
- Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.
- Department of Surgery, Ryhov County Hospital, Jönköping, Sweden.
- Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
ORCID-Profile: Jennifer Park, Pamela Buchwald
Förderung
- Vetenskapsrådet
- Cancerföreningen i Stockholm
- Astma- och Allergiförbundet
- Cancerfonden
Zitieren
APA
Rutegård, M., Myrberg, I. H., Nordenvall, C., Landerholm, K., Jörgren, F., Matthiessen, P., Park, J., Segelman, J., Buchwald, P., & Häggström, J. (2025). Development and validation of an anastomotic risk score for use in a randomized clinical trial on defunctioning stoma use in low anterior resection for rectal cancer. Colorectal Disease. https://doi.org/10.1111/codi.70089
Vancouver
Rutegård M, Myrberg IH, Nordenvall C, Landerholm K, Jörgren F, Matthiessen P, et al. Development and validation of an anastomotic risk score for use in a randomized clinical trial on defunctioning stoma use in low anterior resection for rectal cancer. Colorectal Disease. 2025. doi:10.1111/codi.70089
BibTeX
@article{Rutegrd2025,
author = {Rutegård, Martin and Myrberg, Ida Hed and Nordenvall, Caroline and Landerholm, Kalle and Jörgren, Fredrik and Matthiessen, Peter and Park, Jennifer and Segelman, Josefin and Buchwald, Pamela and Häggström, Jenny},
title = {Development and validation of an anastomotic risk score for use in a randomized clinical trial on defunctioning stoma use in low anterior resection for rectal cancer},
journal = {Colorectal Disease},
year = {2025},
doi = {10.1111/codi.70089}
}
EUVIMED